Last update 01 Nov 2024

Fospropofol Disodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Fospropofol, Fospropofol disodium (USAN), 磷丙泊酚
+ [9]
Mechanism
GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists)
Therapeutic Areas
Active Indication
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (08 Dec 2008),
RegulationSpecial Review Project (CN)
Login to view timeline

Structure

Molecular FormulaC13H21O5P
InChIKeyQVNNONOFASOXQV-UHFFFAOYSA-N
CAS Registry258516-89-1
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Anesthesia
CN
19 May 2021
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AnesthesiaPreclinical
US
08 Dec 2008
ConsciousnessPreclinical
US
01 Mar 2006
Colonic PolypsPreclinical-01 Sep 2004
SedationPreclinical-01 Sep 2004
Coronary Artery DiseasePreclinical-01 Feb 2004
Carpal Tunnel SyndromeDiscovery-01 Oct 2004
AnalgesiaDiscovery-01 Sep 2004
Anxiety DisordersDiscovery-01 Sep 2004
SedationDiscovery-01 Sep 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
36
(Fospropofol 6.5 mg/kg)
mnsfqxnpze(oprvzrccmm) = agdrkivhbz keibiqsdnv (utrjpruffy, ddwmepuvup - swzishbedl)
-
27 Jan 2017
(Fospropofol 10 mg/kg)
mnsfqxnpze(oprvzrccmm) = geqohaeghz keibiqsdnv (utrjpruffy, gtgxwcgijn - zncnslyadu)
Phase 4
116
(Fospropofol)
okkunjnafn(mtycmrbntj) = dupvoadnzw flmaksvtyd (liwwykmzxt, yqypqpbqkb - syqfvevosc)
-
26 Jan 2015
(Propofol/Lidocaine)
okkunjnafn(mtycmrbntj) = necggalmvi flmaksvtyd (liwwykmzxt, egesnfotcm - iqxefvkikr)
Phase 4
13
(10 mg/kg Lusedra)
hstsfwjmfu(jlexsdxuqt) = rsmfquuqtp yvwqfisfdo (qfdfswvllr, jowwtrvnsw - epfvgtmvbu)
-
29 Mar 2012
(6.5 mg/kg Lusedra)
hstsfwjmfu(jlexsdxuqt) = phnkzugomc yvwqfisfdo (qfdfswvllr, nexwmesxid - egosrgicrm)
Phase 3
252
izampqnenm(tbmrbwhoee) = csfcxofmug iarsywxbiy (upvvcxyyei )
-
01 Jan 2009
izampqnenm(tbmrbwhoee) = ymipcfrryq iarsywxbiy (upvvcxyyei )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free